ANDRODERM
Drug
Allergan, Inc.
Total Payments
$78,364
Transactions
113
Doctors
3
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $19,407 | 9 | 3 |
| 2021 | $5,399 | 42 | 0 |
| 2020 | $53,558 | 62 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $78,314 | 110 | 99.9% |
| Food and Beverage | $49.83 | 3 | 0.1% |
Payments by Type
Research
$78,314
110 transactions
General
$49.83
3 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A PHASE IV, MULTI-CENTER, OPEN-LABEL, SINGLE-ARM 24-HOUR AMBULATORY BLOOD PRESSURE MONITORING (ABPM) STUDY OF 16 WEEKS TREATMENT WITH ANDRODERM IN HYPOGONADAL MEN | Allergan, Inc. | $58,957 | 0 |
| A Study to Evaluate Androderm\00AE's Effect on Blood Pressure in Adult Hypogonodal Male Participants | ABBVIE INC. | $8,991 | 0 |
| A Phase IV, Multi-center, Open-label, Single-arm 24-hour Ambulatory Blood Pressure Monitoring (ABPM) Study of 16 Weeks Treatment with Androderm in Hypogonadal Men | ABBVIE INC. | $7,479 | 0 |
| A multicenter, randomized, double-blind, dose-conversion study to evaluate the safety and efficacy of hormone replacement therapy with Armour Thyroid compared to synthetic T4 (levothyroxine) in previously hypothyroid participants who are euthyroid on T4 replacement therapy | ABBVIE INC. | $2,888 | 0 |
Top Doctors Receiving Payments for ANDRODERM
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Renton, WA | $78,314 | 110 |
| , MD | Neurology | Atlanta, GA | $16.61 | 1 |
| Mckenzie Banks | Family | Atlanta, GA | $16.61 | 1 |
| , MD | Internal Medicine | Atlanta, GA | $16.61 | 1 |
Ad
Manufacturing Companies
- Allergan, Inc. $58,957
- ABBVIE INC. $19,407
Product Information
- Type Drug
- Total Payments $78,364
- Total Doctors 3
- Transactions 113
About ANDRODERM
ANDRODERM is a drug associated with $78,364 in payments to 3 healthcare providers, recorded across 113 transactions in the CMS Open Payments database. The primary manufacturer is Allergan, Inc..
Payment data is available from 2020 to 2022. In 2022, $19,407 was paid across 9 transactions to 3 doctors.
The most common payment nature for ANDRODERM is "Unspecified" ($78,314, 99.9% of total).
ANDRODERM is associated with 4 research studies, including "A PHASE IV, MULTI-CENTER, OPEN-LABEL, SINGLE-ARM 24-HOUR AMBULATORY BLOOD PRESSURE MONITORING (ABPM) STUDY OF 16 WEEKS TREATMENT WITH ANDRODERM IN HYPOGONADAL MEN" ($58,957).